In poultry and swine drinking-water delivery, Gongying Qinglan Mixture Veterinary Grade API is not applied as received. The native extract solids are first converted into a water-dispersible premix because the polysaccharide fraction shows delayed wetting at water temperatures below 15°C and clumps rapidly when added directly to bulk tanks. The premix is prepared in a 500 L ribbon blender filled to 60% of gross volume. Main shaft speed is 11 rpm and blade tip speed is 0.8 m·s⁻¹. A geometric pre-blend is required. The API fraction is combined with anhydrous dextrose carrier at a 1:4 w/w ratio for 5 min. The pre-blend is then passed through a 20-mesh conical mill at 1200 rpm before the remaining dextrose and citric acid are added. The final dry blend is screened through an 80-mesh vibrating sieve. Product loss on drying is held between 1.5% w/w and 2.8% w/w to prevent bridging in in-line metering devices. Reconstituted delivery solution is prepared at 100 g/L in potable water with total hardness not exceeding 250 mg/L as CaCO₃ and pH adjusted to 4.8–5.5 with anhydrous citric acid. A 1:50 stock solution is used in proportional dosing pumps on grow-out farms. Holding time for reconstituted solution is 8 h at 25°C and not more than 4 h at 35°C. The terminal product is a 10% w/w water-soluble powder packed in aluminum-foil-lined bags. Batch release testing includes bulk density, LOD, wetting time, and total aerobic microbial count per Ph. Eur. 2.6.12 and USP <61>.

When the Mixture Is Converted into an Injectable, What Sterilization Boundaries Apply?

The injectable route is specified for cattle and swine where rapid plasma levels are required and feed intake is variable. The mixture is dissolved in Water for Injections with a co-solvent system of propylene glycol at 20% v/v. The fluid is heated to 40°C under a nitrogen blanket. Low-shear agitation at 250 rpm is maintained for 30 min to hydrate water-soluble polysaccharides without generating foam. The solution is pH-adjusted to 5.8–6.2 with tromethamine. This pH band is critical. Above 7.0, polyphenolic acids in the mixture undergo oxidative darkening within 2 h. Below 4.5, hemicellulose fractions precipitate as a sticky residue on vessel walls. The bulk solution is prefiltered through a 0.45 µm polyethersulfone membrane and then sterilized through a 0.22 µm PVDF sterilizing-grade filter. Differential pressure across the sterilizing filter is not permitted to exceed 0.8 bar. In-line filter housing is jacketed at 20°C. Filtration capacity varies with lot-specific extract solids. Published data for this specific configuration is limited. Filterability must be confirmed with production-lot material before scale-up. The filtered solution is filled into 100 mL Type II glass vials with chlorobutyl rubber stoppers and sealed under nitrogen overlay. For multi-dose vials, benzyl alcohol is included at 1.5% v/v as preservative. Terminal sterilization by moist heat at 121°C for 15 min is not recommended for this mixture. Pilot records show post-cycle precipitation and pH drift outside the specification. The finished injectable is tested for sterility per Ph. Eur. 2.6.1, bacterial endotoxins per Ph. Eur. 2.6.14, and subvisible particulate matter per Ph. Eur. 2.9.19. The endotoxin limit is set at 0.5 EU/mg of native mixture in the approved dossier. The solution should not be combined with sodium metabisulfite or other oxidizing and reducing preservative systems. Such combinations generate insoluble polyphenol adducts within 72 h at 25°C.

The Fluid-Bed Agglomeration Path Demands a Narrow LOD Band and Low-Shear Screening

Oral granules for multi-species administration are produced by top-spray fluid-bed granulation. The dry blend contains Gongying Qinglan Mixture Veterinary Grade API, lactose monohydrate, and microcrystalline cellulose PH 102 at a ratio of 22:38:40 w/w/w. Povidone K30 is used as binder at 5.0% w/v in purified water. The binder solution is sprayed onto a 120 kg batch in a top-spray fluid-bed granulator equipped with a 0.8 mm two-fluid nozzle. Inlet air temperature is held at 65°C ± 2°C. Product temperature is 35–38°C. Exhaust air humidity is controlled at 35–45% RH. Atomization air pressure is 1.8 bar. Spray rate is 300 g/min. After binder addition, the granulation is tray-dried at 55°C for 6 h until loss on drying is 2.0–3.5% w/w. Dried granules are screened through a 1.5 mm oscillating screen and then a 0.5 mm safety screen. The fines fraction is limited to 10% w/w because excess fines segregate in sachet filling. The terminal dosage form is a 2.5 g single-dose sachet for piglets and calves. Blend uniformity and in-process granule LOD are monitored per 21 CFR 211.110. Leak testing of formed sachets is performed by vacuum decay per ASTM D3078 at -30 kPa. The binder concentration must not exceed 5.0% w/v. At 7.5% w/v povidone K30, granule hardness exceeds 80 N and disintegration in water at 37°C is delayed beyond 10 min. That delay reduces dose release in automated water proportioners. The mixture is incompatible with high-shear wet granulation when impeller speeds exceed 300 rpm for more than 12 min. The shear oxidizes surface polyphenols and produces a darker granule with reduced marker recovery.

Tablet formulation is selected when the dosing route requires feedlot handling without water lines and when individual animal body-weight adjustment is necessary. Direct compression of Gongying Qinglan Mixture Veterinary Grade API is not robust because the extract particles have a mean particle size below 120 µm, poor plastic deformation, and high hygroscopicity. A roll-compacted granulation is used. The API fraction is blended with mannitol, microcrystalline cellulose PH 102, crospovidone, and colloidal silicon dioxide at a ratio of 20:50:25:4:1 w/w/w/w/w. Roller compaction is performed at a roll pressure of 45 kN, roll speed 6 rpm, and gap 2 mm. The compacted ribbon is passed through a 1.0 mm screen. Magnesium stearate is then added at 0.75% w/w and mixed for 3 min. The final blend is compressed on a rotary tablet press with 19 mm × 8 mm capsule-shaped punches. Tablet breaking force is controlled at 80–120 N per USP <1217>. Friability after 100 revolutions is not more than 0.8% w/w per USP <1216>. Disintegration time is not more than 15 min in water at 37°C. The core tablets are film-coated with HPMC 6 cP at a 3.0% w/w weight gain. Coating pan inlet air temperature is 60°C and pan speed is 12 rpm. The terminal product is a 2 g tablet for cattle. Pre-compression LOD must be held at 1.5–2.5% w/w. If LOD falls below 1.0% w/w, capping occurs at the tablet band. If LOD exceeds 3.5% w/w, the tablet sticks to punch faces. Final magnesium stearate mixing should not extend beyond 5 min because the hydrophobic film on the granules delays tablet disintegration beyond the specification.

When Capsules Replace Injection in Companion Animal Practice, Filling-Room Dew Point Controls the Blend

Hard capsule filling is used for canine and feline dosage forms where dosing by body weight is required and where water medication is impractical. The API mixture is dry-filled into size 1 HPMC capsules with a tamping-pin dosator. The blend contains the API mixture at 35% w/w, microcrystalline cellulose PH 105 at 49% w/w, lactose monohydrate at 10% w/w, croscarmellose sodium at 5% w/w, and colloidal silicon dioxide at 1% w/w. Fill weight target is 320 mg ± 5%. Blend LOD is held at 2.0–3.2% w/w before encapsulation. The filling suite is maintained at 22°C ± 2°C and 35–45% RH. Above 45% RH, the API particles gain moisture and powder bridging occurs in the dosator nozzle. Below 35% RH, static charge causes blend adhesion to the capsule bushings. Fill weight uniformity is tested per USP <905>. In-process weight checks are taken every 15 min and after each hopper refill. Dissolution testing uses pH 1.2 medium and 75% release at 45 min per USP <711>. Disintegration time is not more than 30 min per Ph. Eur. 2.9.1. The terminal product is a 300 mg capsule for dogs. For feline variants, lactose monohydrate is replaced by dicalcium phosphate dihydrate at 46% w/w and microcrystalline cellulose is reduced to 13% w/w to avoid lactose-associated loose stools in adult cats. The mixture is not suitable for capsule filling at ambient relative humidity above 50% unless a desiccant-lined feeder is installed. Batch-to-batch variance in the native extract tapped density changes dosator pin settings. The dosator compression spring must be re-qualified when tapped density shifts by more than 0.05 g/mL.

Medicated Feed Premix Carrier Substitution and Trace Metal Contact Limits

In feedmill applications, the mixture is diluted stepwise into a medicated premix before incorporation at the mixer. The first dilution is prepared at 1:10 w/w with fine calcium carbonate in a 200 L ribbon blender for 12 min. The second dilution is prepared at 1:100 w/w with ground corn cobs or rice hulls. The final premix contains 0.5% w/w of the native API mixture. Mineral oil is added at 1.0% w/w after the second dilution to reduce dust generation. Mixer shaft speed is 28 rpm and mixing time is 18 min for a 500 kg batch. Homogeneity is verified by taking 10 samples after mixing. The coefficient of variation for marker content is not more than 5.0%. The terminal product is a 20 kg bag of 0.5% w/w premix for poultry and swine feed. The feeder hopper must not contain residual copper sulfate pentahydrate or ferrous sulfate heptahydrate. Free copper and iron ions accelerate polyphenol oxidation. At 40°C and 75% RH in accelerated storage, marker recovery in a premix containing trace mineral salts fell by 18% after 30 days in an internal monitoring run. Published data for this specific mixture configuration is limited. The observed instability pattern supports segregation of trace mineral premixes. Carrier substitution from calcium carbonate to wheat middlings changes dust control requirements. Calcium carbonate produces a denser, free-flowing premix with less oil absorption than wheat middlings. A switch to wheat middlings at the same 1.0% w/w mineral oil can create clumping in bucket elevators. The oil level must be reduced to 0.5% w/w when wheat middlings are used. Batch records are maintained under HACCP principles and feed hygiene controls described in EU Regulation 2019/4 and ISO 22000:2018.

For calibrated drench gun delivery in calves and lambs, a bulk oral solution is manufactured from the same veterinary-grade API mixture. The mixture is dissolved in a co-solvent system of propylene glycol 15% v/v, glycerol 5% v/v, and purified water to final volume. The vessel is heated to 45–50°C and mixed at 300 rpm for 20 min. Sodium benzoate 0.2% w/v and potassium sorbate 0.15% w/v are added as preservatives. pH is adjusted to 5.0–5.5 with a 10% w/v citric acid solution. The solution is passed through a 10 µm polypropylene bag filter and filled into 1 L amber HDPE bottles with induction-sealed caps. In-use shelf life after first opening is 14 days at 25°C. The finished product is tested for total aerobic microbial count per Ph. Eur. 5.1.4 and for pH per Ph. Eur. 2.2.3. Exact marker degradation rates depend on the CoA polyphenol profile. Published data for this specific mixture configuration is limited. The liquid must not be diluted with alkaline drinking water above pH 7.5. Under alkaline conditions, the polyphenolic acid fraction sediments as a dark precipitate within 60 min. The terminal product is a 100 mg/mL oral solution for calves. The bottle should be stored upright at 15–30°C and protected from light. Dilution in hard water above 300 mg/L as CaCO₃ reduces clarity and may block drench gun nozzles.